Fundz

Passkey Therapeutics Appoints Mandeep Kaur as Chief Medical Officer

PRIVATEMay 19, 2026

Position

Chief Medical Officer

Company

Passkey Therapeutics

Mandeep Kaur
CambridgeBiotechnologyHealth CareTherapeutics

Description

Passkey Therapeutics has announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead the company's clinical and medical strategy, advancing its program of novel drug combinations into clinical studies.

Quick answer

Passkey Therapeutics Appoints Mandeep Kaur as Chief Medical Officer (May 19, 2026). Passkey Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Medical Officer at Passkey Therapeutics?
Passkey Therapeutics named Mandeep Kaur Chief Medical Officer, announced May 19, 2026.
What did Passkey Therapeutics announce on May 19, 2026?
Passkey Therapeutics has announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead the company's clinical and medical strategy, advancing its program of novel drug combinations into clinical studies.
What does Passkey Therapeutics do?
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together.
Where is Passkey Therapeutics based?
Passkey Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
VistaGen (May 19, 2026), Azafaros B.V (May 19, 2026), Orca Bio (May 18, 2026) and VahatiCor (May 18, 2026) also announced leadership changes within 45 days of Passkey Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Passkey Therapeutics, and when

A new leader at Passkey Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Passkey Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Passkey Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Passkey Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Passkey Therapeutics

Location

Cambridge, Massachusetts, United States

About

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Passkey Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Peter
Likely contact at this company
••••••••@••••••••

See Peter's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Passkey Therapeutics's next move

Learn about Strategic plan

Passkey Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.